Astrana Health earnings were $9.5M for the trailing 12 months ending Sep 30, 2025, with -84.7% growth year over year. The latest ASTH earnings report on Sep 30, 2025 announced Q3 2025 earnings of $373.0k, down 96% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASTH reported annual earnings of $43.1M, with -28.9% growth.
ASTH past earnings growth
How has ASTH's earnings growth performed historically?
On ASTH's earnings call on Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q3 2025 earnings per share (EPS) of $0.01, up 97.06% year over year. Total ASTH earnings for the quarter were $373.00 thousand. In the same quarter last year, Astrana Health's earnings per share (EPS) was $0.34.
As of the last Astrana Health earnings report, Astrana Health is currently profitable. Astrana Health's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $9.54 million, a 84.73% decrease year over year.
What was ASTH's earnings growth in the past year?
As of Astrana Health's earnings date in Invalid Date, Astrana Health's earnings has grown -84.73% year over year. This is 97.3 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 12.57%. ASTH earnings in the past year totalled $9.54 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.